vs

Side-by-side financial comparison of AMES NATIONAL CORP (ATLO) and Beta Bionics, Inc. (BBNX). Click either name above to swap in a different company.

Beta Bionics, Inc. is the larger business by last-quarter revenue ($27.6M vs $18.7M, roughly 1.5× AMES NATIONAL CORP). AMES NATIONAL CORP runs the higher net margin — 34.9% vs -79.3%, a 114.1% gap on every dollar of revenue. On growth, Beta Bionics, Inc. posted the faster year-over-year revenue change (56.6% vs 26.7%).

Ames National Corp is a U.S. financial holding company based in Iowa. It operates multiple community banking subsidiaries, offering retail and commercial financial services including deposit accounts, personal and business loans, mortgages, and wealth management, primarily serving consumers and SMEs across central Iowa.

Beta Bionics, Inc. is a medical technology company focused on developing and commercializing advanced automated diabetes management solutions. Its core product is the iLet Bionic Pancreas, a wearable device that automatically adjusts insulin and glucagon delivery for people with Type 1 and Type 2 diabetes, serving primarily the U.S. healthcare market with plans for global expansion.

ATLO vs BBNX — Head-to-Head

Bigger by revenue
BBNX
BBNX
1.5× larger
BBNX
$27.6M
$18.7M
ATLO
Growing faster (revenue YoY)
BBNX
BBNX
+30.0% gap
BBNX
56.6%
26.7%
ATLO
Higher net margin
ATLO
ATLO
114.1% more per $
ATLO
34.9%
-79.3%
BBNX

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
ATLO
ATLO
BBNX
BBNX
Revenue
$18.7M
$27.6M
Net Profit
$6.5M
$-21.9M
Gross Margin
59.5%
Operating Margin
44.3%
-47.4%
Net Margin
34.9%
-79.3%
Revenue YoY
26.7%
56.6%
Net Profit YoY
85.4%
23.6%
EPS (diluted)
$-0.49

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ATLO
ATLO
BBNX
BBNX
Q1 26
$27.6M
Q4 25
$18.7M
$32.1M
Q3 25
$16.6M
$27.3M
Q2 25
$16.1M
$23.2M
Q1 25
$15.5M
$17.6M
Q4 24
$14.7M
Q3 24
$13.5M
Q2 24
$13.5M
Net Profit
ATLO
ATLO
BBNX
BBNX
Q1 26
$-21.9M
Q4 25
$6.5M
$-13.5M
Q3 25
$4.6M
$-14.2M
Q2 25
$4.5M
$-16.9M
Q1 25
$3.4M
$-28.7M
Q4 24
$3.5M
Q3 24
$2.2M
Q2 24
$2.2M
Gross Margin
ATLO
ATLO
BBNX
BBNX
Q1 26
59.5%
Q4 25
59.0%
Q3 25
55.5%
Q2 25
53.8%
Q1 25
50.9%
Q4 24
Q3 24
Q2 24
Operating Margin
ATLO
ATLO
BBNX
BBNX
Q1 26
-47.4%
Q4 25
44.3%
-50.2%
Q3 25
34.5%
-62.5%
Q2 25
35.0%
-85.5%
Q1 25
27.4%
-105.7%
Q4 24
29.4%
Q3 24
19.4%
Q2 24
19.0%
Net Margin
ATLO
ATLO
BBNX
BBNX
Q1 26
-79.3%
Q4 25
34.9%
-41.9%
Q3 25
27.5%
-52.1%
Q2 25
28.0%
-72.6%
Q1 25
22.3%
-162.5%
Q4 24
23.8%
Q3 24
16.4%
Q2 24
16.2%
EPS (diluted)
ATLO
ATLO
BBNX
BBNX
Q1 26
$-0.49
Q4 25
$-0.16
Q3 25
$-0.33
Q2 25
$-0.39
Q1 25
$-0.93
Q4 24
Q3 24
Q2 24

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ATLO
ATLO
BBNX
BBNX
Cash + ST InvestmentsLiquidity on hand
$126.8M
$199.5M
Total DebtLower is stronger
$18.4M
Stockholders' EquityBook value
$207.9M
$271.2M
Total Assets
$2.1B
$304.4M
Debt / EquityLower = less leverage
0.09×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ATLO
ATLO
BBNX
BBNX
Q1 26
$199.5M
Q4 25
$126.8M
$219.1M
Q3 25
$108.2M
$228.7M
Q2 25
$95.2M
$249.7M
Q1 25
$163.4M
$231.5M
Q4 24
$101.2M
Q3 24
$59.0M
Q2 24
$63.4M
Total Debt
ATLO
ATLO
BBNX
BBNX
Q1 26
Q4 25
$18.4M
Q3 25
Q2 25
Q1 25
Q4 24
$20.0M
Q3 24
Q2 24
Stockholders' Equity
ATLO
ATLO
BBNX
BBNX
Q1 26
$271.2M
Q4 25
$207.9M
$287.6M
Q3 25
$200.6M
$294.8M
Q2 25
$193.0M
$301.6M
Q1 25
$183.1M
$313.8M
Q4 24
$174.7M
Q3 24
$183.4M
Q2 24
$167.1M
Total Assets
ATLO
ATLO
BBNX
BBNX
Q1 26
$304.4M
Q4 25
$2.1B
$328.7M
Q3 25
$2.1B
$330.0M
Q2 25
$2.1B
$330.0M
Q1 25
$2.2B
$338.0M
Q4 24
$2.1B
Q3 24
$2.1B
Q2 24
$2.1B
Debt / Equity
ATLO
ATLO
BBNX
BBNX
Q1 26
Q4 25
0.09×
Q3 25
Q2 25
Q1 25
Q4 24
0.11×
Q3 24
Q2 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ATLO
ATLO
BBNX
BBNX
Operating Cash FlowLast quarter
$21.3M
Free Cash FlowOCF − Capex
$20.7M
FCF MarginFCF / Revenue
110.8%
Capex IntensityCapex / Revenue
3.4%
Cash ConversionOCF / Net Profit
3.28×
TTM Free Cash FlowTrailing 4 quarters
$34.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ATLO
ATLO
BBNX
BBNX
Q1 26
Q4 25
$21.3M
$-8.6M
Q3 25
$2.8M
$-8.7M
Q2 25
$4.0M
$-13.6M
Q1 25
$7.1M
$-20.0M
Q4 24
$14.3M
Q3 24
$3.1M
Q2 24
$3.9M
Free Cash Flow
ATLO
ATLO
BBNX
BBNX
Q1 26
Q4 25
$20.7M
$-10.5M
Q3 25
$2.6M
$-10.0M
Q2 25
$3.9M
$-15.4M
Q1 25
$6.9M
$-20.3M
Q4 24
$14.0M
Q3 24
$3.0M
Q2 24
$3.8M
FCF Margin
ATLO
ATLO
BBNX
BBNX
Q1 26
Q4 25
110.8%
-32.8%
Q3 25
16.0%
-36.7%
Q2 25
24.2%
-66.2%
Q1 25
44.8%
-115.1%
Q4 24
94.9%
Q3 24
22.5%
Q2 24
28.1%
Capex Intensity
ATLO
ATLO
BBNX
BBNX
Q1 26
Q4 25
3.4%
5.9%
Q3 25
0.6%
4.7%
Q2 25
0.7%
7.7%
Q1 25
1.3%
1.9%
Q4 24
2.0%
Q3 24
0.5%
Q2 24
0.7%
Cash Conversion
ATLO
ATLO
BBNX
BBNX
Q1 26
Q4 25
3.28×
Q3 25
0.60×
Q2 25
0.89×
Q1 25
2.07×
Q4 24
4.07×
Q3 24
1.40×
Q2 24
1.78×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons